S3, E3. Connecting voices - challenge and opportunity in patient group-industry collaborations.

Welcome to Episode 3 of Season 3 of Rarely Heard.

In this episode, we explore how new and orphan medicines are developed in the UK, shedding light on both the opportunities and the challenges along the way, including: the commercial realities, the personal stakes for patients urgently seeking treatment, and the broader system that shapes these journeys. Today, we examine the complex relationships between patient organisations and the pharmaceutical industry - unpacking what it means to collaborate, advocate, and push for progress from both sides of the table.

Please listen below!